HTLV type 1 and 2 are both involved in actively spreading epidemics, affecting over 15
million people worldwide. HTLV-1 has been described as the more clinically significant one …

The human T-cell lymphotropic virus type 1 (HTLV-1) is an oncogenic retrovirus that is
transmitted from mother to child, particularly through prolonged breastfeeding; between …

We report 10 HTLV-I virus seropositive subjects, eight of them with HTLV-I associated
myelopathy (HAM), two of them also infected with HIV as well as two asymptomatic HTLV-I+ …

BACKGROUND: Human T-lymphotropic virus type 1 (HTLV-1) is known to cause HTLV-
associated myelopathy (HAM)/tropical spastic paraparesis and adult T cell leukemia. A …

HTLV-1 is a retrovirus associated with a myriad of clinical conditions, especially
hematological and neurological ones. Regarding nervous system diseases, it is of utmost …

Recent reports have demonstrated that human T lymphotropic virus type 1 (HTLV-1) is
associated with other neurological abnormalities in addition to HTLV-1–associated …

The human T-cell lymphotropic virus type 1 (HTLV-1) infects 5-10 million people worldwide
and causes fatal and disabling diseases in a significant proportion of them. A chronic …

From an index case of tropical spastic paraparesis (TSP), four generations of a Brazilian
family of African descent were investigated for human T-lymphotropic virus type I (HTLV-I) …

We performed a serologic survey for antibodies to HTLV-I/II in the course of a longitudinal
study of the neurologic complications of HIV-1 infection. Nine (3.7%) of 242 HIV-1 …

In this study, the epidemiological and clinical features observed in solely HTLV-II-infected
individuals were compared to those in patients co-infected with HIV-1. A total of 380 subjects …